Search results for interleukin-6 inhibitor

Roche announced that the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) by a near unanimous (10-1) vote recommended approval of Actemra (tocilizumab), a novel interleukin read more »
Discuss   Add this link to...  Bury